Is Align Technology Stock Outperforming the Nasdaq?

Company Overview - Align Technology, Inc. (ALGN) is a leader in the medical device sector, valued at a market cap of $12.1 billion, and is headquartered in Tempe, Arizona [1] - The company is known for pioneering the digital transformation of orthodontics with its flagship product, the Invisalign system, and operates an integrated "Align Digital Platform" [1] Market Position - ALGN is classified as a "large-cap stock" due to its market cap exceeding $10 billion, highlighting its size and influence in the medical instruments & supplies industry [2] - The company has treated over 22 million patients globally and is expanding its ecosystem with products like iTero intraoral scanners and exocad CAD/CAM software [2] Stock Performance - Currently, ALGN is trading 18.7% below its 52-week high of $208.31, reached on July 29, 2025, but has seen a 4% increase over the past three months, outperforming the Nasdaq Composite's 3.2% decline [3] - Year-to-date, ALGN shares are up 8.5%, while the Nasdaq Composite has fallen by 3.7% [5] - Over the past 52 weeks, ALGN has gained 2%, which is significantly lower than the Nasdaq Composite's 26% increase [5] Technical Analysis - ALGN has been trading above its 200-day moving average since early January, although it has recently started trading below its 50-day moving average since early March [5] Financial Performance - In Q4, ALGN reported revenue of $1.05 billion, a 5.3% year-over-year increase, slightly beating analyst expectations of $1.03 billion [7] - The adjusted EPS for the quarter climbed 34.8% to $3.29, surpassing the consensus estimate of $2.97, driven by strong demand for clear aligners and traction in dental service organizations [7]